Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurotherapeutics
Metadata
Title
The blood-brain barrier: Bottleneck in brain drug development
Author
William M. Pardridge
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 1/2005
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1602/neurorx.2.1.3

Other articles of this Issue 1/2005

Neurotherapeutics 1/2005 Go to the issue

OriginalPaper

Drug transport to brain with targeted nanoparticles

OriginalPaper

Blood-brain barrier active efflux transporters: ATP-binding cassette gene family

OriginalPaper

RNA interference and nonviral targeted gene therapy of experimental brain cancer

OriginalPaper

Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems

OriginalPaper

Active efflux across the blood-brain barrier: Role of the solute carrier family

OriginalPaper

Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy